Tag: European Union

Transaction in Own Shares

ORION CORPORATION
PRESS RELEASE
21 JULY 2025 at 10:30 EEST          

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hims & Hers (HIMS) or Sarepta (SRPT) To Contact Him Directly To Discuss Their Options

Transaction in Own Shares

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

AB Akola Group, an investment company that owns one of the largest agricultural and food production groups in the Baltic States, has temporarily postponed the construction of a biomethane gas production plant in the Kaišiadorys district through its indirectly controlled company AB Kaišiadorių paukštynas. This investment project remains part of AB Akola Group's long-term development plans.

The Board of Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) approved unaudited Telia Lietuva, AB Interim Financial Statements, prepared according to International Financial Reporting Standards as adopted by the European Union, for 6 months’ period ended 30 June 2025.

Transaction in Own Shares

Transaction in Own Shares

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Sarepta To Contact Him Directly To Discuss Their Options

LEI: 213800NNT42FFIZB1T09 
16 July 2025